Healthcare Services Company Research Reports

Healthcare services represent a huge segment of the medical industry. Companies involved in the healthcare services market provide testing or treatment of a disease or dysfunction. All services are implemented by professionals in medicine, nursing, dentistry such as public health practitioners, community health workers, etc..

Kindred Healthcare Inc., Patient Home Monitoring Corp., Aikchol Hospital Public Co. Ltd., America Service Group Inc., Apollo Hospitals Enterprise Ltd., Coventry Health Care Inc. are among top companies that participate in the health services market.

The Catalogue offers innumerable research reports dedicated to the companies active in the healthcare services market. The research reports include profiles of large-cap, middle-sized and small companies. Data on companies’ historical development, financial performance, marketing strategies and structure are offered in the reports. Information on market trends, opportunities, barriers and igniters can be found in the research reports too.

Found 829 publications
Global Stem Cell Partnering 2010-2016: Deal trends, players, financials and forecasts US$ 2,995.00

... -life Stem Cell deals Access to Stem Cell contract documents Leading Stem Cell deals by value since 2010 Most active Stem Cell dealmakers since 2010 In Global Stem Cell Partnering 2010-2016: Deal trends, players, financials and forecasts, the available deals ...

Apr, 2016 370 pages
Global Molecular Diagnostics 2010-2016: Deal trends, players, financials and forecasts US$ 2,995.00

... Case studies of real-life Molecular Diagnostics deals Access to Molecular Diagnostics contract documents Leading Molecular Diagnostics deals by value since 2010 Most active Molecular Diagnostics dealmakers since 2010 In Global Molecular Diagnostics Partnering 2010-2016: Deal trends, players, financials and ...

Apr, 2016 447 pages
Global In Vitro Diagnostics 2010-2016: Deal trends, players, financials and forecasts US$ 2,995.00

... In Vitro Diagnostics deals Access to In Vitro Diagnostics contract documents Leading In Vitro Diagnostics deals by value since 2010 Most active In Vitro Diagnostics dealmakers since 2010 In Global In Vitro Diagnostics Partnering 2010-2016: Deal trends, players, financials and forecasts, the available deals ...

Apr, 2016 660 pages
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2015 US$ 3,495.00

... Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the manufacturing and supply ...

Oct, 2015 3314 pages
Global Learning Disability Partnering 2010-2015 US$ 1,495.00

... learning disability partnering deals Top learning disability deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Learning Disability Partnering 2010-2015 provides understanding and access to the learning disability partnering deals ...

Jul, 2015 100 pages
Vitmark-Ukraine SP TOV in Health and Wellness (Ukraine) US$ 572.00

Vitmark-Ukraine popularizes and actively promotes the ideas of healthy development of the consumers and society as a whole. Over the forecast period, Vitmark ... company profiles. Product coverage: Health and Wellness by Category, Health and Wellness by Prime Positioning, Health and Wellness by Type. Data ...

Jul, 2015 2 pages
Rozmay PP in Health and Wellness (Ukraine) US$ 572.00

Rozmay PP plans to increase its range with new kinds of diabetic products ... of snapshot company profiles. Product coverage: Health and Wellness by Category, Health and Wellness by Prime Positioning, Health and Wellness by Type. Data coverage: market ...

Jul, 2015 2 pages
OTCPharm OAO in Consumer Health (Russia) US$ 150.00

OTCPharm’s goal is to further strengthen its leading position within Russian pharmaceuticals. ... . Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management. Data ...

Nov, 2015 2 pages
Auriga International SA in Beauty and Personal Care (Belgium) US$ 572.00

... closely with Belgian universities regarding research and development, Auriga International will continue to focus on rejuvenation of the face, cellulite and liposuction ... Shower, Colour Cosmetics, Deodorants, Depilatories, Fragrances, Hair Care, Mass Beauty and Personal Care, Men's Grooming, Oral Care, Oral ...

Jul, 2015 2 pages
Akvion ZAO in Consumer Health (Russia) US$ 572.00

Akvion ZAO has stated that the development of ... Moreover, the company is open to partnerships through exclusive distribution in Russia and the CIS. Euromonitor International Local Company ... Why buy this report? Get a detailed picture of the Consumer Health market; Pinpoint growth sectors and identify factors ...

Jul, 2015 2 pages
Akrikhin OAO in Consumer Health (Russia) US$ 150.00

Akrikhin positions itself as socially responsible and ... The company intends to strengthen its industry position in Russia by continuing to leverage on its strong brand loyalty ... : Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight ...

Nov, 2015 2 pages
McKesson Corporation Market Share Analysis US$ 1,000.00

McKesson Corporation Market Share Analysis Summary GlobalData’s new report, “McKesson Corporation Market Share Analysis” provides in-depth information on McKesson Corporation’s market position in the different medical equipment markets it operates in. The report provides McKesson Corporation market share ...

Sep, 2011 163 pages
STAAR Surgical Company Market Share Analysis US$ 1,000.00

... into the medical equipment business of STAAR Surgical. The report provides key information relating to STAAR Surgical medical equipment revenue, market share by sector and country, financial ... - Revenues for the medical equipment markets and sub-sectors by country and region. - Provides the share of market and sub sectors by country and ...

Nov, 2009 26 pages
Sanofi- Aventis Market Share Analysis US$ 1,000.00

... , analysis and strategic insight into the medical equipment business of Sanofi-Aventis. The report provides key information relating to Sanofi-Aventis medical equipment revenue, market share by sector and country, financial and SWOT analysis of the ...

Nov, 2009 31 pages
Ortho-Clinical Diagnostics Inc. Market Share Analysis US$ 1,000.00

... into the medical equipment business of Ortho-Clinical Diagnostics Inc.. The report provides key information relating to Ortho-Clinical Diagnostics Inc. medical equipment revenue, market share by sector and country, financial ... - Revenues for the medical equipment markets and sub-sectors by country and region. - Provides the share of market and sub sectors by country and ...

Nov, 2009 75 pages
MAQUET GmbH and Co. KG Market Share Analysis US$ 1,000.00

... insight into the medical equipment business of MAQUET GmbH & Co.KG. The report provides key information relating to MAQUET GmbH & Co.KG medical equipment revenue, market share by sector ...

Nov, 2009 109 pages
KARL STORZ GmbH and Co. KG Market Share Analysis US$ 1,000.00

... insight into the medical equipment business of KARL STORZ GmbH & Co. KG. The report provides key information relating to KARL STORZ GmbH & Co. KG medical equipment revenue, market share by sector ...

Nov, 2009 114 pages
Air Liquide Market Share Analysis US$ 1,000.00

Air Liquide Market Share Analysis Summary GlobalData’s new report, “Air Liquide Market Share Analysis” provides in-depth information on Air Liquide’s market position in the different medical equipment markets it operates in. The report provides Air Liquide’s market share information in one ...

Oct, 2010 83 pages
Global Royalty Financing Deals in Pharma, Biotech and Diagnostics 2010-2015 US$ 2,995.00

... licensed, royalty rates, license fees, upfront and milestone payments. This report provides details of the latest partnering deals which disclose a royalty rate ...

Jun, 2015 896 pages
Global Regenerative Medicine Partnering 2010-2016: Deal trends, players, financials and forecasts US$ 2,995.00

The Global Regenerative Medicine Partnering 2010-2016: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements ...

Apr, 2016 660 pages
Global Co-development Deals in Pharma, Biotech & Diagnostics 2010-2015 US$ 2,995.00

... development deals by value since 2010 Most active co-development dealmakers since 2010 The leading co-development partnering resources In Global Co-development Deals in Pharma, Biotech & Diagnostics 2010-2015 available deals ...

Apr, 2015 1005 pages
Autoimmune Disease Partnering Terms and Agreements US$ 2,995.00

... contract document. Chapter 7 provides a comprehensive directory of all autoimmune disease partnering deals signed and announced since 2010. The chapter is organized by specific autoimmune therapy focus, including inflammatory bowel disease, psoriasis, endometriosis, lupus, type ...

Mar, 2015 1092 pages
Autoimmune Partnering Terms and Agreements US$ 2,995.00

... contract document. Chapter 7 provides a comprehensive directory of all autoimmune partnering deals signed and announced since 2010. The chapter is organized by specific autoimmune therapy focus, including inflammatory bowel disease, psoriasis, endometriosis, lupus, type ...

Mar, 2015 1000 pages
Life Science Deals and Alliances of Jan-Mar 2014 US$ 995.00

A review of life science partnering trends and comprehensive directory of deals and alliances announced during Jan to Mar or Q1, 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past quarter of the year. The report series ...

Apr, 2014 500 pages
Vertex Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
United Therapeutics Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
The Medicines Company Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies. On demand company ... does the company insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon ...

Apr, 2016
Targacept Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Seattle Genetics Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Ranbaxy Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Nektar Therapeutics Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Morphosys Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Isis Pharmaceuticals Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Intermune Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Genmab Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Fresenius Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Exelixis Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Enzo Biochem Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Emergent BioSolutions Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Elan Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Cubist Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Cangene Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Biota Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Biocon Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Bavarian Nordic Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Anika Therapeutics Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Alkermes Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Wrinkles Partnering 2009-2014 US$ 695.00

... , stage of development, technology type Wrinkles Partnering 2009-2014 provides understanding and access to the wrinkles partnering deals and agreements entered ... by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online ...

Nov, 2014 100 pages
Valeant Partnering Deals and Alliances 2010 to 2016 US$ 1,495.00

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies ... insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for ...

Apr, 2016
Sun Damage Partnering 2009-2014 US$ 995.00

... stage of development, technology type Sun Damage Partnering 2009-2014 provides understanding and access to the sun damage partnering deals and agreements ... of sun damage partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license ...

Nov, 2014 100 pages
1 2 3 4 5 >
Skip to top